BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Icosavax

Icosavax logo

Founded
2018
Geography
United States of America based
Funding
$161 M

We are committed to developing safe and effective vaccines against infectious diseases that address important unmet medical needs to save lives and improve health. We were founded on breakthrough computationally-designed virus-like particle technology, developed at the Institute for Protein Design and exclusively licensed for a variety of infectious disease indications from the University of Washington.


vaccine development infectious disases

Technologies

AI Companies (Drug Discovery)  

R&D Platform

-


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet